Matinas BioPharma Holdings (MTNB) Operating Leases (2019 - 2026)
Matinas BioPharma Holdings' Operating Leases was $464,000 in Q1 2026, down 75.7% from $1.91 million a year earlier and down 28.9% from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Operating Leases at Matinas BioPharma Holdings came in at $653,000, down 69.1% from FY2024.
- Operating Leases has now declined for four consecutive years, with a five-year compound annual growth rate of -27.7% (FY2020 to FY2025).
- In earlier years, Operating Leases was $2.12 million in FY2024 (-26.5%), $2.88 million in FY2023 (-18.6%), $3.53 million in FY2022 (-14.7%) and $4.14 million in FY2021 (+25.3%).
- The Q1 2026 figure marks the lowest quarterly Operating Leases in data going back to Q1 2019.
- Compared with a year earlier, Operating Leases has declined for 15 straight quarters, with an average decline of 39.4% over the last eight quarters.
- The best year-over-year quarter for Operating Leases over five years was Q3 2021 (growth of 26.3%); the worst was Q1 2026 (a decline of 75.7%).
- Per Business Quant data, MTNB's Operating Leases in the three quarters before Q1 2026 was $653,000 (Q4 2025), $1.47 million (Q3 2025) and $1.7 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Matinas BioPharma Holdings | 16.27 Mn | 3.68 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 464,000.00 |
| Dec 31, 2025 | 653,000.00 |
| Sep 30, 2025 | 1.47 Mn |
| Jun 30, 2025 | 1.70 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Dec 31, 2024 | 2.12 Mn |
| Sep 30, 2024 | 2.32 Mn |
| Jun 30, 2024 | 2.51 Mn |
| Mar 31, 2024 | 2.70 Mn |
| Dec 31, 2023 | 2.88 Mn |
| Sep 30, 2023 | 3.05 Mn |
| Jun 30, 2023 | 3.22 Mn |
| Mar 31, 2023 | 3.38 Mn |
| Dec 31, 2022 | 3.53 Mn |
| Sep 30, 2022 | 3.68 Mn |
| Jun 30, 2022 | 3.84 Mn |
| Mar 31, 2022 | 3.99 Mn |
| Dec 31, 2021 | 4.14 Mn |
| Sep 30, 2021 | 4.28 Mn |
| Jun 30, 2021 | 3.12 Mn |
API Access
Matinas BioPharma Holdings Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();